Vnitr Lek 2019, 65(2):149-156 | DOI: 10.36290/vnl.2019.029
Anaphylactic symptoms and anaphylactic shock
- Ústav klinické imunologie a alergologie LF UK a FN Hradec Králové
Anaphylactic symptoms and anaphylactic shock are serious, rapidly developing and potentially fatal systemic reactions occurring after contact with the trigger, followed by release of a number of substances that affect vascular permeability, smooth muscle tone of blood vessels and bronchi with activation of the systemic inflammatory cascade. From a pathophysiological point of view, it can be an IgE-mediated immune response followed by massive release of biologically active mediators from mast cells and basophils (IgE dependent). If the mastocyt/basophil is degranulated via a direct IgE-free pathway, it is non-allergic (non-IgE dependent, anaphylactoid anaphylaxis). The diagnosis of anaphylaxis is determined on the basis of clinical criteria, taking into account the need to initiate therapy in a life-threatening condition without delay. Adrenaline is the first-line drug in the treatment of anaphylaxis and there is no contraindication to its use. Early provision of venous intake is essential for the patient to develop hypotension.
Keywords: anaphylaxis; IgE dependent anaphylaxis; non IgE dependent anaphylaxis; management of anaphylaxis
Received: November 22, 2018; Accepted: November 26, 2018; Published: February 1, 2019 Show citation
References
- Muraro A, Roberts, G, Worm M et al. Anaphylaxis: guidelines from European Academy of Allergy and Clinical Immunology. Allergy 2014; 69(8): 1026-1045. Dostupné z DOI: <http://doi:10.1111/all.12437>.
Go to original source...
Go to PubMed...
- Petrů V. Chyby a omyly v diagnostice a léčbě anafylaxe. Postgrad Med 2017; 19(3): 285-290.
- Tanno LK, Ganem F, Demoly P et al. Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10. Allergy 2012; 67(6): 783-789. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1398-9995.2012.02829.x>.
Go to original source...
Go to PubMed...
- Panesar SS, Nwaru B, Hickstein L et al. The epidemiology of anaphylaxis in Europe: protocol for a systematic review. Clin Transl Allergy 2013; 3(1): 9. Dostupné z DOI: <http://dx.doi.org/10.1186/2045-7022-3-9>.
Go to original source...
Go to PubMed...
- Worm A, Moneret-Vautrin AM, Scherer K et al. First European data from the network of severe allergic reaction (NORA). Allergy 2014; 69(10): 1397-1404. Dostupné z DOI: <http://dx.doi.org/10.1111/all.12475>.
Go to original source...
Go to PubMed...
- Finkelman F, Khodoun M, Strait R. Human IgE-independent systemic anaphylaxis. J Allergy Clin Immunol 2016; 137(6): 1674-1680. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jaci.2016.02.015>.
Go to original source...
Go to PubMed...
- Petrů V, Krčmová I. Anafylaktická reakce. Maxdorf Jessenius: Praha 2006: 3-95. ISBN 80-7345-099-2.
- Krejsek J, Andrýs C, Krčmová I. Imunologie člověka. Garamon: Hradec Králové: 2016: 213-221. ISBN 978-80-86472-74-4.
- Mehr S, Liew WK, Tey D et al. Clinical predictors for biphasic reactions in children presenting with anaphylaxis. Clin Exp Allergy 2009; 39(9): 1390-1396. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2222.2009.03276.x>.
Go to original source...
Go to PubMed...
- Park HJ, Kim SH. Factors associated with shock in anaphylaxis. Am J Emerg Med 2012; 30(9): 1674-1678. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ajem.2012.01.015>.
Go to original source...
Go to PubMed...
- Simons FER, Clark S, Camargo CA Jr. Anaphylaxis in the community: learning from the survivors. J Allergy Clin Immunol 2009; 124(2): 301-306. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jaci.2009.03.050>.
Go to original source...
Go to PubMed...
- Soar J, Perkins GD, Abbas G et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution. Resuscitation 2010; 81(10): 1400-1433. Dostupné z DOI: <http://dx.doi.org/10.1016/j.resuscitation.2010.08.015>.
Go to original source...
Go to PubMed...
- Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007; 119(4): 1016-1018. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jaci.2006.12.622>.
Go to original source...
Go to PubMed...
- Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30(8): 1144-1150.
Go to original source...
Go to PubMed...
- Braganza SC, Acworth JP, McKinnon DR et al. Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child 2006; 91(2): 159-163. Dostupné z DOI: <http://dx.doi.org/10.1136/adc.2004.069914>.
Go to original source...
Go to PubMed...
- Calvani M, Cardinale F, Martelli A et al. Risk factors for severe pediatric food anaphylaxis in Italy. Pediatr Allergy Immunol 2011; 22(8): 813-819. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1399-3038.2011.01200.x>.
Go to original source...
Go to PubMed...
- Gonzalez-Perez A, Aponte Z, Vidaurre CF et al. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom databas review. J Allergy Clin Immunol 2010; 125(5): 1098-1104. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jaci.2010.02.009>.
Go to original source...
Go to PubMed...
- Hamilton MJ, Hornick JL, Akin C et al. Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations. J Allergy Clin Immunol 2011; 128(1): 147-152. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jaci.2011.04.037>.
Go to original source...
Go to PubMed...
- Moneret-Vautrin DA. Drugs as risk factors of food anaphylaxis in adults. Facteurs de risque d'anaphylaxie alimentaire severe Role confirme de certaines classes de medicaments. Med Sci (Paris) 2010; 26(8-9): 719-723. Dostupné z DOI: <http://dx.doi.org/10.1051/medsci/2010268-9719>.
Go to original source...
Go to PubMed...
- Niggemann B, Beyer K. Time for a new grading system for allergic reaction? Allergy 2016; 71(2): 135-136. Dostupné z DOI: <http://dx.doi.org/10.1111/all.12765>.
Go to original source...
Go to PubMed...
- De Schryver S, Halbrich M, Clarke A et al. Tryptase levels in children presenting with anaphylaxis. Temporal trends and associated factors. J Allergy Clin Immunol 2016; 137(4): 1138-1142. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jaci.2015.09.001>.
Go to original source...
Go to PubMed...
- Noimark L, Wales J, Du Toit G et al. The use of adrenaline autoinjectors by children and teenagers. Clin Exp Allergy 2012; 42(2): 284-292. Dostupné z DOI: <http://doi:10.1111/j.1365-2222.2011.03912.x>.
Go to original source...
Go to PubMed...
- Lieberman P. The 10-second rule and other myths about epinephrine and autoinjectors. Ann Allergy Asthma Immunol 2011; 107(3): 189-190. Dostupné z DOI: <http://doi10.1016/j.anai.2011.07.007>.
Go to original source...
Go to PubMed...
- Simons FER, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 2001; 108(5): 871-873. Dostupné z DOI: <http://10.1067/mai.2001.119409>.
Go to original source...
Go to PubMed...
- Simons F, Ardusso L, Bilo M et al. 2012 Update: World Allergy Organization guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol 2012; 12(4): 389-399. Dostupné z DOI: <http://dx.doi.org/10.1097/ACI.0b013e328355b7e4>.
Go to original source...
Go to PubMed...
- Lin RY, Curry A, Pesola GR et al. Improved outcomes outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med 2000; 36(5): 462-468. Dostupné z DOI: <http://dx.doi.org/10.1067/mem.2000.109445>.
Go to original source...
- Thomas M. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J 2005; 22(4): 272-273. Dostupné z DOI: <http://dx.doi.org/10.1136/emj.2005.023507>.
Go to original source...
Go to PubMed...
- Váchová M., Panzner P. Diagnostika alergie na Hymenopter. Alergie 2017; 19(3): 173-180.
- Gagné C. Peanut OIT Therapy Sees Success, Boosting Hope for FDA Approval. Allergic Living: Food Allergy News 2018. Dostupné z WWW: <https://www.allergicliving.com/2018/02/20/peanut-oit-therapy-sees-success-boosting-hope-for-fda-approval/>.